Gaudium IVF

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE0P8B01020
  • NSEID: GAUDIUMIVF
  • BSEID: 544709
INR
95.65
6.77 (7.62%)
BSENSE

Apr 10

BSE+NSE Vol: 58.73 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

58.73 lacs (97.75%) Volume

Shareholding (Feb 2026)

FII

9.24%

Held by 8 FIIs

DII

5.05%

Held by 2 DIIs

Promoter

71.29%

Why is Gaudium IVF and Women Health Ltd falling/rising?

08-Apr-2026

As of 07-Apr, Gaudium IVF and Women Health Ltd's stock price is at 78.50, down 0.63%, underperforming its sector by 1.49%. Despite a 10.08% gain over the past week and increased investor participation, negative market sentiment and being below key moving averages are contributing to the stock's decline.

As of 07-Apr, Gaudium IVF and Women Health Ltd's stock price is currently at 78.50, reflecting a decrease of 0.5, or 0.63%. This decline can be attributed to the stock underperforming its sector by 1.49% today. Although the stock has shown a positive return of 10.08% over the past week, it is still lower than the longer-term moving averages, specifically being below the 20-day, 50-day, 100-day, and 200-day moving averages. <BR><BR>Additionally, while there has been a notable increase in investor participation, with a delivery volume rising by 36.83% against the 5-day average, the overall market sentiment appears to be negative, as indicated by the Sensex's performance, which has declined by 5.45% over the past month. This combination of underperformance relative to the sector and the broader market trends likely contributes to the current downward movement in the stock price.

View full answer

Why is Gaudium IVF and Women Health Ltd falling/rising?

09-Apr-2026

As of 08-Apr, Gaudium IVF and Women Health Ltd's stock price is currently at 78.96, reflecting a modest gain of 0.47% over the past week and a stronger increase of 4.40% over the past month, despite underperforming its sector today. The stock shows mixed performance indicators, being above its 5-day moving average but below longer-term averages, alongside a decrease in investor participation.

As of 08-Apr, Gaudium IVF and Women Health Ltd's stock price is rising, currently at 78.96, reflecting a change of 0.39 (0.5%) upwards. This increase comes despite the stock underperforming its sector by -0.56% today. Over the past week, the stock has shown a modest gain of +0.47%, while it has performed significantly better over the past month with a rise of +4.40%, contrasting with the Sensex, which has declined by -1.72% in the same period. <BR><BR>However, it is important to note that the stock is currently higher than its 5-day moving averages but lower than its 20-day, 50-day, 100-day, and 200-day moving averages, indicating mixed performance in the context of longer-term trends. Additionally, there has been a decrease in investor participation, with delivery volume falling by -18.6% against the 5-day average, which could signal a lack of strong buying interest. Despite these factors, the stock's current rise can be attributed to its recent performance relative to the broader market, particularly in the last month.

View full answer

Why is Gaudium IVF and Women Health Ltd falling/rising?

10-Apr-2026

As of 09-Apr, Gaudium IVF and Women Health Ltd's stock price is rising to Rs 89.50, reflecting a 12.93% increase. The stock has outperformed the sector and benchmark indices significantly over various time frames, indicating a strong upward trend.

As of 09-Apr, Gaudium IVF and Women Health Ltd's stock price is rising, currently at Rs 89.50, which reflects an increase of Rs 10.25 or 12.93%. The stock has outperformed the sector by 12.06% today and has shown a consecutive gain over the last two days, rising 13.91% during this period. <BR><BR>In terms of performance relative to the benchmark, the stock has increased by 15.75% over the past week, while the Sensex has only risen by 4.52%. Over the past month, Gaudium IVF has gained 19.92%, contrasting with a decline of 1.20% in the Sensex. <BR><BR>Today's trading has been characterized by high volatility, with an intraday volatility of 5.63%. The stock reached an intraday high of Rs 94, marking an increase of 18.61%. Additionally, there has been a significant rise in investor participation, with delivery volume on April 8 increasing by 96.41% compared to the 5-day average. <BR><BR>Furthermore, the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend. Overall, these factors contribute to the rising stock price of Gaudium IVF and Women Health Ltd.

View full answer

Which are the latest news on Gaudium IVF?

10-Apr-2026
No latest news for Gaudium IVF found.

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 702 Cr (Micro Cap)

stock-summary
P/E

37.00

stock-summary
Industry P/E

57

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.27

stock-summary
Return on Equity

36.63%

stock-summary
Price to Book

14.34

Revenue and Profits:
Net Sales:
25 Cr
(Quarterly Results - Dec 2025)
Net Profit:
4 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Gaudium IVF And Women Health Limited Has Updated The Exchange On The Query Received From BSE Limited Vide Its Email Dated April 07 2026 Seeking Additional Details For Corporate Announcement Dated April 06 2026 Filed Under Regulation 30 Of SEBI (LODR) Regu

07-Apr-2026 | Source : BSE

Gaudium IVF and Women Health Limited has updated the Exchange on the query received from BSE Limited vide its email dated April 07 2026 seeking additional details for Corporate Announcement dated April 06 2026 filed under Regulation 30 of SEBI (LODR) Regulations 2015

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)

06-Apr-2026 | Source : BSE

Intimation Under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations)

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015 ( Listing Regulations)

01-Apr-2026 | Source : BSE

Intimation Under Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015 (Listing Regulations)

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
19.98
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
24.53%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
14.35%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
37
Industry P/E
57
Price to Book Value
15.32
EV to EBIT
27.40
EV to EBITDA
25.43
EV to Capital Employed
12.29
EV to Sales
12.01
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
44.85%
ROE (Latest)
41.01%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
KST
Dow Theory
OBV
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Feb 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 8 FIIs (9.24%)

Promoter with highest holding

Manika Khanna (70.73%)

Highest Public shareholder

Meru Investment Fund Pcc-cell 1 (2.96%)

Individual Investors Holdings

13.52%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -38.17% vs 64.52% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -64.78% vs 169.55% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14.19",
          "val2": "22.95",
          "chgp": "-38.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.83",
          "val2": "13.28",
          "chgp": "-56.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.12",
          "val2": "0.51",
          "chgp": "119.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "3.18",
          "val2": "9.03",
          "chgp": "-64.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "41.09%",
          "val2": "57.86%",
          "chgp": "-16.77%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Gaudium IVF"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Gaudium IVF"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 12.98% vs 18.65% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 11.96% vs 25.49% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "59.00",
          "val2": "52.22",
          "chgp": "12.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "27.86",
          "val2": "25.07",
          "chgp": "11.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.39",
          "val2": "0.54",
          "chgp": "157.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "18.63",
          "val2": "16.64",
          "chgp": "11.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "47.22%",
          "val2": "48.01%",
          "chgp": "-0.79%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
14.19
22.95
-38.17%
Operating Profit (PBDIT) excl Other Income
5.83
13.28
-56.10%
Interest
1.12
0.51
119.61%
Exceptional Items
0.00
0.00
Standalone Net Profit
3.18
9.03
-64.78%
Operating Profit Margin (Excl OI)
41.09%
57.86%
-16.77%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is -38.17% vs 64.52% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -64.78% vs 169.55% in Sep 2025

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
59.00
52.22
12.98%
Operating Profit (PBDIT) excl Other Income
27.86
25.07
11.13%
Interest
1.39
0.54
157.41%
Exceptional Items
0.00
0.00
Standalone Net Profit
18.63
16.64
11.96%
Operating Profit Margin (Excl OI)
47.22%
48.01%
-0.79%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 12.98% vs 18.65% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is 11.96% vs 25.49% in Mar 2024

stock-summaryCompany CV
About Gaudium IVF and Women Health Ltd stock-summary
stock-summary
Gaudium IVF and Women Health Ltd
Micro Cap
Healthcare Services
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available